Axsome Therapeutics, Inc. Profile Avatar - Palmy Investing

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of majo…
Biotechnology
US, New York [HQ]
Strategy & Leadership

Executives & BofD Beta

Total Compensation ($)

Scope

Executives

Yet No Data For Executives

Directors

Yet No Data For Directors

C-Suite and VPs/SVPs

Yet No Data For Executives

Board of Directors (BofD)

Yet No Data For Directors

End of AXSM's Analysis
CIK: 1579428 CUSIP: 05464T104 ISIN: US05464T1043 LEI: - UEI: -
Secondary Listings
AXSM has no secondary listings inside our databases.